(+)-Chrysanthenone

Details

Top
Internal ID 109dd99f-d3ae-4002-8d18-97b4cd039c70
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Bicyclic monoterpenoids
IUPAC Name (1S,5R)-2,7,7-trimethylbicyclo[3.1.1]hept-2-en-6-one
SMILES (Canonical) CC1=CCC2C(=O)C1C2(C)C
SMILES (Isomeric) CC1=CC[C@H]2C(=O)[C@@H]1C2(C)C
InChI InChI=1S/C10H14O/c1-6-4-5-7-9(11)8(6)10(7,2)3/h4,7-8H,5H2,1-3H3/t7-,8+/m0/s1
InChI Key IECBDTGWSQNQID-JGVFFNPUSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H14O
Molecular Weight 150.22 g/mol
Exact Mass 150.104465066 g/mol
Topological Polar Surface Area (TPSA) 17.10 Ų
XlogP 1.70
Atomic LogP (AlogP) 2.18
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
(+)-Chrysanthenone
Chrysanthenone D-form [MI]
5706LMQ84R
841NXH6XEV
UNII-5706LMQ84R
38301-80-3
Bicyclo(3.1.1)hept-2-en-6-one, 2,7,7-trimethyl-, (1S,5R)-
UNII-841NXH6XEV
CHRYSANTHENONE [MI]
CHRYSANTHENONE, (+/-)-
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of (+)-Chrysanthenone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9974 99.74%
Caco-2 + 0.5547 55.47%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability + 0.8857 88.57%
Subcellular localzation Mitochondria 0.5296 52.96%
OATP2B1 inhibitior - 0.8608 86.08%
OATP1B1 inhibitior + 0.9459 94.59%
OATP1B3 inhibitior + 0.9494 94.94%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.8993 89.93%
P-glycoprotein inhibitior - 0.9710 97.10%
P-glycoprotein substrate - 0.9692 96.92%
CYP3A4 substrate - 0.5731 57.31%
CYP2C9 substrate - 0.7977 79.77%
CYP2D6 substrate - 0.8166 81.66%
CYP3A4 inhibition - 0.8309 83.09%
CYP2C9 inhibition - 0.7575 75.75%
CYP2C19 inhibition + 0.5593 55.93%
CYP2D6 inhibition - 0.8873 88.73%
CYP1A2 inhibition - 0.7658 76.58%
CYP2C8 inhibition - 0.9881 98.81%
CYP inhibitory promiscuity - 0.5888 58.88%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7600 76.00%
Carcinogenicity (trinary) Non-required 0.4705 47.05%
Eye corrosion - 0.8825 88.25%
Eye irritation + 0.9641 96.41%
Skin irritation + 0.6041 60.41%
Skin corrosion - 0.9286 92.86%
Ames mutagenesis - 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6216 62.16%
Micronuclear - 0.8600 86.00%
Hepatotoxicity + 0.7125 71.25%
skin sensitisation + 0.8755 87.55%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity - 0.5667 56.67%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity + 0.5736 57.36%
Acute Oral Toxicity (c) III 0.7560 75.60%
Estrogen receptor binding - 0.8994 89.94%
Androgen receptor binding - 0.6616 66.16%
Thyroid receptor binding - 0.8509 85.09%
Glucocorticoid receptor binding - 0.9023 90.23%
Aromatase binding - 0.9328 93.28%
PPAR gamma - 0.8547 85.47%
Honey bee toxicity - 0.8461 84.61%
Biodegradation + 0.6000 60.00%
Crustacea aquatic toxicity + 0.5700 57.00%
Fish aquatic toxicity + 0.9476 94.76%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.82% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.30% 96.09%
CHEMBL2581 P07339 Cathepsin D 84.20% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.44% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.76% 97.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 81.87% 91.11%

Cross-Links

Top
PubChem 11789373
NPASS NPC260976